Literature DB >> 28238307

Comparing pyloromyotomy outcomes across Canada.

Alexander C Ednie1, Ofer Amram2, Nadine Schuurman2, Natalie L Yanchar3.   

Abstract

BACKGROUND: Changing patterns of referral and management of hypertrophic pyloric stenosis (HPS) in North America have recently been described. Comfort with perioperative management, anesthesia, and corrective surgery have been cited as reasons for these changes. Our primary objective was to assess pyloromyotomy outcomes between different hospital types across Canada. The secondary objective was to geospatially map all pyloromyotomies to identify regions of higher HPS incidence across Canada.
METHODS: Data of all pyloromyotomies done between 2011 and 2013 were acquired from Canadian Institute for Health Information (CIHI). Complication rates and length of hospital stay (LOS) were analyzed. Postal codes for each patient were used to geospatially map regions of higher HPS incidence.
RESULTS: A total of 1261 pyloromyotomies were assessed. There was no difference in LOS or complication rates between different hospital types or surgeon group. Open pyloromyotomies were done in 75% of the cases. Several regions of higher HPS incidence were identified across Canada.
CONCLUSION: This study found no difference in complication rate or LOS stay between hospital type and surgeon type across Canada. This may reflect a previously identified referral trend in the United States towards pediatric centers. Several regions of higher HPS incidence were identified, and may aid in identifying genetic elements causing HPS. LEVEL OF EVIDENCE: 2c. Crown
Copyright © 2017. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Incidence; National; Outcomes; Pyloromyotomy

Mesh:

Year:  2017        PMID: 28238307     DOI: 10.1016/j.jpedsurg.2017.01.021

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  1 in total

1.  Trends and surgical outcomes of laparoscopic versus open pyloromyotomy.

Authors:  William C Kethman; Alex H S Harris; Mary T Hawn; James K Wall
Journal:  Surg Endosc       Date:  2018-01-16       Impact factor: 4.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.